Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-26

Clinical Trial Update: Esmolol to Control Adrenergic Storm in Septic Shock- ROLL-IN 2 [Phase 2]

View source ↗

Summary

Phase 2 trial investigating esmolol to control adrenergic storm in septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esmolol (esmolol)

Snippet

Sponsor: Samuel Brown | Conditions: Septic Shock | Phase 2 | Status: UNKNOWN